| Status EpilepticusThe Harrison's Practice Preview allows you to view 5 FREE complete topics or conduct a search that delivers abstracts for more than 450 medical topics.
For full access, please subscribe today!
 |
Specific Treatments
Treatment protocol: General measures
- Assess carefully for evidence of respiratory or cardiovascular insufficiency.
- With careful monitoring and standard airway protection, patients usually do not require intubation (if intubation is necessary, use short-acting paralytics).
- Establish intravenous access and administer:
- Perform a brief medical and neurologic examination.
- Treat hyperthermia.
- Send samples for laboratory studies aimed at identifying metabolic abnormalities.
Treatment protocol: Anticonvulsant therapy
-
Lorazepam (0.1 mg/kg IV at 2 mg/min)
- Additional emergency drug therapy may not be required if seizures stop and the cause of SE is rapidly corrected.
- If seizures continue
-
Phenytoin (20 mg/kg IV at 50 mg/min) or fosphenytoin (20 mg/kg phenytoin sodium equivalents [PE] IV at 150 mg/min)
- Monitor blood pressure; electrocardiogram; and, if possible, EEG during infusion.
- Side effects: Phenytoin can cause precipitous fall in blood pressure if given too quickly, especially in elderly patients.
- Precautions: Do not administer phenytoin with 5% dextrose in water as phenytoin precipitates at low pH. This is not a problem with fosphenytoin.
- If seizures are not controlled, a repeat bolus of phenytoin (510 mg/kg) or fosphenytoin (510 mg/kg) may be given.
- If seizures continue
- May add phenobarbital (20 mg/kg IV at 5075 mg/min)
- If lorazepam and phenytoin are ineffective in terminating SE, many physicians now bypass use of phenobarbital and proceed to anesthesia with midazolam or propofol, especially if patient displays severe systemic disturbances or has had seizures for longer than 60 minutes.
- If seizures continue
The Harrison's Practice Preview allows you to view 5 FREE complete topics or conduct a search that delivers abstracts for more than 450 medical topics.
For full access, please subscribe today!
 |
| |